Galveston, TX, United States of America

Hua-Yu Wang

This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hua-Yu Wang. Retrieved from https://idiyas.com/inventor/hua-yu-wang-s1a92amf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hua-Yu Wang

Introduction

Hua-Yu Wang is a notable inventor based in Galveston, TX (US). He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors. His work has led to the filing of multiple patents, showcasing his innovative approach to scientific challenges.

Latest Patents

Hua-Yu Wang holds 2 patents. His latest patents include "Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof." This invention relates to the preparation and application of quinoline-derived small molecule inhibitors targeting NNMT, which has implications for various therapeutic uses.

Career Highlights

Wang is affiliated with the University of Texas System, where he continues to advance his research and innovation. His work is characterized by a commitment to exploring new avenues in drug development and molecular biology.

Collaborations

Some of his notable coworkers include Stanley J Watowich and Harshini Neelakantan. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Hua-Yu Wang's contributions to the field of biochemistry through his patents and research at the University of Texas System highlight his role as an influential inventor. His work continues to pave the way for future innovations in medicine and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…